9 results
Oral Antihypertensive Medications - Selection by Comorbidities
Comorbidities: 
 • Stable Angina, HFpEF, HFrEF, AFib, TAA/Marfan, Aortic
Antihypertensive Medications ... Comorbidities: • Stable ... HFpEF, HFrEF, AFib ... Comorbidities #pharmacology ... #table #management
Beta Blockers - Pharmacology Comparison Table
Metoprolol:
 • Receptors: β1
 • Indications: Rate control of a-fib/a-flutter, Suppression
Comparison Table ... Suppression of VT, Stable ... : Stable angina, ... : Stable angina, ... #Comparison #Table
Summary of characteristics of Antianginal Drugs

DRUG CLASS, ADVERSE EFFECTS 
 AND DRUG 
INTERACTIONS 

#Antianginal #Medications #Cardiology
#Antianginal #Medications ... #Cardiology #Pharmacology ... #Management #Therapy ... #Table #Overview
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
#management #algorithm ... #pharmacology # ... treatment #medications ... #table #pharmacotherapy ... #decisionaid #cardiology
Table of Common Rate Control Agents via AHA/ACC/HRS Guidelines #Management #Pharm #EM #IM #Cardiology #Afib #Common
Table of Common ... HRS Guidelines #Management ... Pharm #EM #IM #Cardiology ... #Afib #Common # ... #Table
Cardioversion of patient’s with hemodynamically stable AF.
**Remember unstable patients should be immediately cardioverted**
#Managment #Cardiology #AFib #AtrialFibrillation
hemodynamically stable ... **Remember unstable ... cardioverted** #Managment ... #Cardiology #AFib ... Cardioversion #Algorithm
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
Treatment - GDMT for stage ... #CHF #sCHF #HeartFailure ... #HFrEF #Pharmacology ... #Management #Treatment ... #StageC #Cardiology
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
#differential #algorithm ... #management #cardiology ... #treatment #table ... #foamed #heartfailure ... icu #clinical #pharmacology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Allergies to medications ... functional status - Able ... metabolic equivalent able ... Stable patients ... one post op Cardiology